AI assistant
Sending…
CStone Pharmaceuticals — Director's Dealing 2022
Jul 14, 2022
50715_rns_2022-07-14_6eb6bda9-1d8a-4204-b066-dba18f2d2a84.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
14 July 2022
Possible offer
Disclosure of dealings in the shares of Yankuang Energy Group Company Limited
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Desof rsec | criptionelevanturities | Deof | scriptionproducts | Nature ofdealings | Nurefesecwhi | mber ofrenceurities toch the | dcd | Maturityate /losing outate | Referenceprice | Totalpaid | amount/ received | Reba(inth | sultantlancecludingose of any | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| derivativesrelate | person withwhom there isan agreementorunderstanding) | ||||||||||||||||
| CICC FinancialTrading Limited | 13 July2022 | Derivatives | Other types ofproducts | Closing out of aderivative contract | 42,000 | 15 July 2022 | $21.4199 | $899,634.7000 | 332,000 |
End
==> picture [71 x 43] intentionally omitted <==
Public Disclosure Form
Note:
CICC Financial Trading Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.
CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.
More from CStone Pharmaceuticals
Transaction in Own Shares
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 27
Annual Report
2026
Apr 27
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 22
Share Issue/Capital Change
2026
Apr 22
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 20